Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study

Federico Gobbi, Emmanuel Bottieau, Olivier Bouchaud, Dora Buonfrate, Fernando Salvador, Gerardo Rojo-Marcos, Paola Rodari, Jan Clerinx, Begoña Treviño, Juan Paulo Herrera-Ávila, Andreas Neumayr, Guido Calleri, Andrea Angheben, Camilla Rothe, Lorenzo Zammarchi, Massimo Guerriero, Zeno Bisoffi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Loa loa infection is endemic in limited areas of West-Central Africa. Loiasis has been associated with excess mortality, but clinical studies on its treatment are scant, particularly outside endemic areas, due to the rarity of cases diagnosed. Methodology/Principal findings: With this retrospective TropNet (European Network for Tropical Medicine and Travel Health) study, we aimed at outlining the treatment schedules followed by different reference centers for tropical medicine across Europe. We gathered information about 238 cases of loiasis, 165 of which had follow up data. The regimens followed by the different centers were heterogeneous. The drugs most frequently administered were: diethylcarbamazine alone (74/165, 45.1%), ivermectin alone (41/165, 25%), albendazole + ivermectin (21/164, 11.6%), ivermectin + diethylcarbamazine (16/165, 9.7%). Conclusions/Significance: The management of loiasis substantially differs across specialized travel clinics in Europe. These discrepancies could be due to different local protocols as well as to (un)availability of the drugs. An harmonization of clinical protocols for the treatment of loiasis would be suggested across reference centers for tropical medicine in Europe.

Original languageEnglish
Article numbere0006917
JournalPLoS Neglected Tropical Diseases
Volume12
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Loiasis
Tropical Medicine
Ivermectin
Retrospective Studies
Diethylcarbamazine
Pharmaceutical Preparations
Loa
Central Africa
Albendazole
Western Africa
Therapeutics
Clinical Protocols
Appointments and Schedules
Mortality
Health
Infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study. / Gobbi, Federico; Bottieau, Emmanuel; Bouchaud, Olivier; Buonfrate, Dora; Salvador, Fernando; Rojo-Marcos, Gerardo; Rodari, Paola; Clerinx, Jan; Treviño, Begoña; Herrera-Ávila, Juan Paulo; Neumayr, Andreas; Calleri, Guido; Angheben, Andrea; Rothe, Camilla; Zammarchi, Lorenzo; Guerriero, Massimo; Bisoffi, Zeno.

In: PLoS Neglected Tropical Diseases, Vol. 12, No. 11, e0006917, 01.11.2018.

Research output: Contribution to journalArticle

Gobbi, F, Bottieau, E, Bouchaud, O, Buonfrate, D, Salvador, F, Rojo-Marcos, G, Rodari, P, Clerinx, J, Treviño, B, Herrera-Ávila, JP, Neumayr, A, Calleri, G, Angheben, A, Rothe, C, Zammarchi, L, Guerriero, M & Bisoffi, Z 2018, 'Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study', PLoS Neglected Tropical Diseases, vol. 12, no. 11, e0006917. https://doi.org/10.1371/journal.pntd.0006917
Gobbi, Federico ; Bottieau, Emmanuel ; Bouchaud, Olivier ; Buonfrate, Dora ; Salvador, Fernando ; Rojo-Marcos, Gerardo ; Rodari, Paola ; Clerinx, Jan ; Treviño, Begoña ; Herrera-Ávila, Juan Paulo ; Neumayr, Andreas ; Calleri, Guido ; Angheben, Andrea ; Rothe, Camilla ; Zammarchi, Lorenzo ; Guerriero, Massimo ; Bisoffi, Zeno. / Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study. In: PLoS Neglected Tropical Diseases. 2018 ; Vol. 12, No. 11.
@article{8c4b931df5d14f338382978bf8114235,
title = "Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study",
abstract = "Background: Loa loa infection is endemic in limited areas of West-Central Africa. Loiasis has been associated with excess mortality, but clinical studies on its treatment are scant, particularly outside endemic areas, due to the rarity of cases diagnosed. Methodology/Principal findings: With this retrospective TropNet (European Network for Tropical Medicine and Travel Health) study, we aimed at outlining the treatment schedules followed by different reference centers for tropical medicine across Europe. We gathered information about 238 cases of loiasis, 165 of which had follow up data. The regimens followed by the different centers were heterogeneous. The drugs most frequently administered were: diethylcarbamazine alone (74/165, 45.1{\%}), ivermectin alone (41/165, 25{\%}), albendazole + ivermectin (21/164, 11.6{\%}), ivermectin + diethylcarbamazine (16/165, 9.7{\%}). Conclusions/Significance: The management of loiasis substantially differs across specialized travel clinics in Europe. These discrepancies could be due to different local protocols as well as to (un)availability of the drugs. An harmonization of clinical protocols for the treatment of loiasis would be suggested across reference centers for tropical medicine in Europe.",
author = "Federico Gobbi and Emmanuel Bottieau and Olivier Bouchaud and Dora Buonfrate and Fernando Salvador and Gerardo Rojo-Marcos and Paola Rodari and Jan Clerinx and Bego{\~n}a Trevi{\~n}o and Herrera-{\'A}vila, {Juan Paulo} and Andreas Neumayr and Guido Calleri and Andrea Angheben and Camilla Rothe and Lorenzo Zammarchi and Massimo Guerriero and Zeno Bisoffi",
year = "2018",
month = "11",
day = "1",
doi = "10.1371/journal.pntd.0006917",
language = "English",
volume = "12",
journal = "PLoS Neglected Tropical Diseases",
issn = "1935-2727",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Comparison of different drug regimens for the treatment of loiasis—A TropNet retrospective study

AU - Gobbi, Federico

AU - Bottieau, Emmanuel

AU - Bouchaud, Olivier

AU - Buonfrate, Dora

AU - Salvador, Fernando

AU - Rojo-Marcos, Gerardo

AU - Rodari, Paola

AU - Clerinx, Jan

AU - Treviño, Begoña

AU - Herrera-Ávila, Juan Paulo

AU - Neumayr, Andreas

AU - Calleri, Guido

AU - Angheben, Andrea

AU - Rothe, Camilla

AU - Zammarchi, Lorenzo

AU - Guerriero, Massimo

AU - Bisoffi, Zeno

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: Loa loa infection is endemic in limited areas of West-Central Africa. Loiasis has been associated with excess mortality, but clinical studies on its treatment are scant, particularly outside endemic areas, due to the rarity of cases diagnosed. Methodology/Principal findings: With this retrospective TropNet (European Network for Tropical Medicine and Travel Health) study, we aimed at outlining the treatment schedules followed by different reference centers for tropical medicine across Europe. We gathered information about 238 cases of loiasis, 165 of which had follow up data. The regimens followed by the different centers were heterogeneous. The drugs most frequently administered were: diethylcarbamazine alone (74/165, 45.1%), ivermectin alone (41/165, 25%), albendazole + ivermectin (21/164, 11.6%), ivermectin + diethylcarbamazine (16/165, 9.7%). Conclusions/Significance: The management of loiasis substantially differs across specialized travel clinics in Europe. These discrepancies could be due to different local protocols as well as to (un)availability of the drugs. An harmonization of clinical protocols for the treatment of loiasis would be suggested across reference centers for tropical medicine in Europe.

AB - Background: Loa loa infection is endemic in limited areas of West-Central Africa. Loiasis has been associated with excess mortality, but clinical studies on its treatment are scant, particularly outside endemic areas, due to the rarity of cases diagnosed. Methodology/Principal findings: With this retrospective TropNet (European Network for Tropical Medicine and Travel Health) study, we aimed at outlining the treatment schedules followed by different reference centers for tropical medicine across Europe. We gathered information about 238 cases of loiasis, 165 of which had follow up data. The regimens followed by the different centers were heterogeneous. The drugs most frequently administered were: diethylcarbamazine alone (74/165, 45.1%), ivermectin alone (41/165, 25%), albendazole + ivermectin (21/164, 11.6%), ivermectin + diethylcarbamazine (16/165, 9.7%). Conclusions/Significance: The management of loiasis substantially differs across specialized travel clinics in Europe. These discrepancies could be due to different local protocols as well as to (un)availability of the drugs. An harmonization of clinical protocols for the treatment of loiasis would be suggested across reference centers for tropical medicine in Europe.

UR - http://www.scopus.com/inward/record.url?scp=85056548890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056548890&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0006917

DO - 10.1371/journal.pntd.0006917

M3 - Article

C2 - 30383753

AN - SCOPUS:85056548890

VL - 12

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

SN - 1935-2727

IS - 11

M1 - e0006917

ER -